Ingredient or product comparison
Best GHK-Cu Cosmetic Dosage for Topical Anti-Aging: Product Comparison
0.1–0.5% Standard cream base Minimal to no measurable improvement in collagen synthesis or elasticity Excellent. No irritation reported Subtherapeutic for anti-aging purposes. Cosmetic claim only 1–1.5% Liposomal or cyclodextrin complex 12–15% improvement in s
This source-based comparison does not add ratings or recommend a winner.
- 0.1–0.5%
- Standard cream base
- Minimal to no measurable improvement in collagen synthesis or elasticity
- Excellent. No irritation reported
- Subtherapeutic for anti-aging purposes. Cosmetic claim only
- 1–1.5%
- Liposomal or cyclodextrin complex
- 12–15% improvement in skin elasticity, 9–11% increase in dermal thickness
- Very good. Mild transient redness in fewer than 5% of users
- Minimum effective concentration for measurable extracellular matrix remodeling
- 2–3%
- Liposomal or nanoparticle delivery
- 18–22% improvement in elasticity, 16–19% increase in thickness, visible fine line reduction
- Good. Mild irritation in 8–12% during initial use, resolves within 2 weeks
- Optimal therapeutic range. Maximum efficacy without proportional increase in adverse events
- 4–5%
- Various formulations
- 20–24% improvement (not statistically superior to 2–3%)
- Moderate. Erythema and stinging in 18–25% of users, prolonged sensitization in compromised skin
- Increased risk profile without clinical benefit. Not recommended for routine use
- Above 5%
- Rare in commercial products
- No published data demonstrating superior outcomes
- Poor. Inflammatory response, copper toxicity risk at chronic high-dose exposure
- Outside therapeutic window. Pro-oxidant effects exceed anti-aging benefits